SummaryThe recommended treatment for eosinophilic myocarditis (EM), pathologically defined as myocardial inflammation with eosinophil infiltration, is corticosteroids. Although EM has a wide variety of clinical features including the degree of eosinophilic infiltration, there have been no reports on how patients with EM should be treated with corticosteroids irrespective of their pathological findings.Thirty-seven consecutive patients with acute myocarditis hospitalized in our institute between 1996-2009 were enrolled. Excluding those with secondary EM such as Loeffler's endocarditis, hypereosinophilic syndrome, and ChurgStrauss Syndrome, together with drug-induced allergic myocarditis, the subjects were divided into 2 groups according to the existence of eosinophils in the myocardial interstitium observed in endomyocardial biopsy specimens. There were no differences in the clinical characteristics on admission between the 2 groups: with (group EM, n = 22) and without (group lymphocytic myocarditis (LM), n = 7) eosinophilic infiltrates irrespective of pathological differences. The treatment policy has been consistent in our institution: intensive hemodynamic observation and support without corticosteroid administration, not only in LM but also in idiopathic EM. There was no significant difference in clinical recovery in the acute phase as indicated by the hospitalization period, left ventricular ejection fraction, or long-term prognosis in EM compared to LM.A conventional management strategy for idiopathic EM without corticosteroid administration can improve the prognosis in the acute and chronic phases, similar to that of LM. (Int Heart J 2011; 52: 110-113) Key words: Eosinophilic myocarditis, Endomyocardial biopsy, Corticosteroid therapy E osinophilic myocarditis (EM) is a relatively rare condition. Although the etiology of EM is not always apparent, several causes have been identified, including hypersensitivity to medicine or some other substance with the heart as the target organ. The spectrum of clinical presentation is wide, and EM is likely to lead to progressive myocardial damage with destruction of the conduction system and then refractory heart failure. It is widely known that EM demonstrates cardiac symptoms with pathological findings of infiltration of eosinophils and degranulation in the myocardium. It has been recommended EM be treated with corticosteroid therapy, according to the guidelines 1) but such is not the case regarding viral myocarditis. In previous reports, some cases of EM, including those with a history of severe left ventricle (LV) dysfunction and aborted sudden death, showed dramatic responses to corticosteroid therapy.2,3) In one case report, an intravenous bolus of methylprednisolone (1 g/day for three days) followed by 1 mg/kg/day oral prednisolone with gradual tapering for one year resulted in an improvement of symptoms, a reduction in the eosinophil count, and increased LV ejection fraction as shown by echocardiography. 4) Also, some reports have shown that conventional managem...